ioa-244
Small moleculeexperimental
Clinical trial activity
6 trials · 4 clinical orgs · 0 marketing orgs
Phase 1
5
Phase 2
4
Phase 3
0
Phase 4
0
Earliest trial started Feb 25, 2020 (NCT04328844)
Timeline
Indications
Mechanism of action
Chemistry & pharmacology
Loading structure…
SMILES
O=C(c1nn(-c2ccc(CN3CCOCC3)cc2)c2c1CS(=O)(=O)c1c(F)cccc1-2)N1CCOCC1- Mol. weight
- 526.59 g/mol
- Lipinski Ro5
- 1 violation(s)
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL3683575 ↗
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07203391 | Phase 1 | Dec 1, 2025 | University of New South Wales |
| NCT06887803 | Phase 1/Phase 2 (Phase 2) | Nov 17, 2025 | iOnctura |
| NCT06644183 | Phase 1/Phase 2 (Phase 2) | Apr 30, 2025 | Department of Defense, Harvard University |
| NCT06879717 | Phase 1/Phase 2 (Phase 2) | Apr 30, 2025 | iOnctura |
| NCT06717126 | Phase 2 | Dec 31, 2024 | iOnctura |
| NCT04328844 | Phase 1 | Feb 25, 2020 | iOnctura |
Showing 6 of 6 trials
Page 1 / 1
Organizations
Research & Development (4)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| iOnctura | For profit | 4 | 4 | 2 | 2020 |
| Department of Defense | Government | 1 | 0 | 1 | 2025 |
| Harvard University | Academic/Hospital | 1 | 1 | 1 | 2025 |
| University of New South Wales | Academic/Hospital | 1 | 1 | 1 | 2025 |
4 organizations
Page 1 / 1